SCHEMBL7708576

SCHEMBL7708576

CCC1CCC(C(=O)OC)=Cc2ccccc21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 3/20 0.42
CA9 Q16790 3/20 0.42
DRD2 P14416 1/20 0.39
DRD4 P21917 1/20 0.39
DRD3 P35462 1/20 0.39
HTR5A P47898 1/20 0.39
CYP11B1 P15538 1/20 0.37
CYP11B2 P19099 1/20 0.37
ALDH1A1 P00352 5/20 0.36
KDM4E B2RXH2 4/20 0.36
HPGD P15428 4/20 0.36
HSD17B10 Q99714 4/20 0.36
GAA P10253 4/20 0.36
GLA P06280 3/20 0.36
CASP1 P29466 3/20 0.36
CASP7 P55210 3/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
TDP1 Q9NUW8 2/20 0.36
CRBN Q96SW2 1/20 0.36
NPSR1 Q6W5P4 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7714911 0.90 CA12 (0.40) CA12CA9DRD2DRD4DRD3
SCHEMBL7712525 0.82 CA12 (0.45) CA12CA9DRD2DRD4DRD3
SCHEMBL7714513 0.80 CA12 (0.43) CA12CA9ALDH1A1KDM4EHPGD
SCHEMBL7714399 0.75 MAOA (0.32) CYP11B1CYP11B2
SCHEMBL7712477 0.73 MTNR1B (0.38) DRD2ALDH1A1KDM4EHPGDHSD17B10
SCHEMBL7911204 0.70 CA12 (0.50) CA12CA9ALDH1A1KDM4EHPGD
SCHEMBL31090834 0.70 CA12 (0.50) CA12CA9ALDH1A1KDM4EHPGD
SCHEMBL4181532 0.69 MTNR1A (0.40) CA12CA9ALDH1A1KDM4EHPGD
SCHEMBL7708862 0.69 CA12 (0.43) CA12CA9ALDH1A1KDM4ESMN1; SMN2
SCHEMBL7378104 0.68 CA12 (0.48) CA12CA9ALDH1A1KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6369110-B1 PROPHYLACTIC AGENT FOR DISEASES CAUSED BY THE ACCELERATION OF THE SODIUM/PROTON EXCHANGE TRANSPORT SYSTEM SUMITOMO PHARMACEUTICALS COMPANY (JP) 2002-04-09 US disclosed
EP-1083166-A1 NOVEL SUBSTITUTED GUANIDINE DERIVATIVES AND PROCESS FOR PRODUCING THE SAME SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 2001-03-14 EP disclosed